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 ABSTRACT 
Objective:  To examine uptake in the first six pilot centres of the English Bowel Scope 
Screening (BSS) programme.  
Setting: Roll-out of the BSS programme, which invites adults aged 55 for a once off 
Flexible Sigmoidoscopy (FS), began in early 2013. This analysis covers 21,187 
invitations sent by the six pilot centres during the first 14 months of the programme 
(March 2013 - May 2014).  
Method: We used multivariate logistic regression analysis to examine variation in 
uptake by gender, socioeconomic deprivation (using the Index of Multiple Deprivation), 
area-based ethnic diversity (proportion of non-white residents), screening centre, and 
appointment time (routine: daytime vs out of hours: evening/weekend).  
Results: Uptake was 43.1%. Men were more likely to attend than women (45% vs 
42%; OR 1.136, 95% CI 1.076, 1.199, p <0.001). Combining data across centres, there 
was a socioeconomic gradient in uptake, which ranged from 33% in the most deprived 
to 53% in the least deprived quintile. Areas with the highest level of ethnic diversity also 
had lower uptake (39%) than other areas (41-47%) (all p<0.02), but there was no 
gradient. Individuals offered a routine appointment were less likely to attend than those 
offered an out of hours appointment (42% vs. 44%; OR 0.931, 95% CI 0.882, 0.983, p 
= 0.01). Multivariate analyses confirmed independent effects of deprivation, gender and 
centre but not ethnic diversity or appointment time.   
 Conclusion: Early indications of uptake are encouraging. Future efforts should focus 
on increasing public awareness of the programme and reducing socioeconomic 
inequalities.  
Key Words: Colorectal Cancer, Screening, Flexible Sigmoidoscopy, Bowel Scope, 
Uptake, Appointments, Socioeconomic Deprivation. 
 
 INTRODUCTION 
Colorectal cancer (CRC) is the third most frequently diagnosed cancer worldwide 
(700,000 deaths worldwide per year), and the fourth leading cause of cancer deaths.1,2  
In the UK, it is the second most common cause of cancer death.3 In 2006, the National 
Health Service (NHS) set up an organised CRC Screening Programme (called the 
Bowel Cancer Screening Programme; BCSP) in England. The programme is based on 
biennial guaiac-based Faecal Occult Blood testing (gFOBt) which is now offered to all 
adults aged 60-74 years. Trial data on gFOBt show a clear benefit in CRC mortality, 
but no evidence of a reduction in incidence;4 so the test is excellent in terms of earlier 
diagnosis but not contributing to prevention. 
 
In contrast, endoscopic screening, through its capacity to detect and remove polyps, 
has been shown to reduce CRC incidence as well as mortality. In the UK Flexible 
Sigmoidoscopy (FS) Trial, a single FS exam (between age 55 and 64 years) reduced 
incidence by 23% and 33%  and mortality by 31% and 43%  in the total and the 
screened population respectively.5  Other quality studies have also found positive 
results with a subsequent meta-analysis concluding that offering FS screening can 
reduce CRC incidence by around 18% and mortality by 28%, increasing to 32% and 
50% respectively when screening is adhered to, and thereby supporting its potential 
use as a strategy to prevent CRC.6,7 Indeed, a more recently published population-
based trial from Norway provides  
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further evidence of how screening using FS can help significantly reduce CRC 
incidence and mortality with an 11 year follow-up.8   
 
The English BCSP started the national roll-out of the ‘Bowel Scope Screening (BSS) 
Programme’, offering a once-off FS to everyone aged 55, in March 2013. A phased roll-
out to ensure workforce capacity is in progress and began with six screening centres 
(South of Tyne, West Kent, Norwich and Norfolk, London (St Mark’s), Wolverhampton, 
and Surrey). The BSS programme is expected to be rolled out across all centres by 
2016 (see Figure 1) with full population coverage from 2018.9 
 
Like all screening programmes, reaping the full public health impact of BSS depends, 
to a large degree, on high uptake, but wherever CRC screening has been 
implemented, and whatever the modality, it has always underperformed compared to 
breast or cervical screening. In the gFOBt programme, uptake of the first 2.6 million 
invitations was 54% overall; however, this varied from less than 35% uptake in the most 
socioeconomically deprived quintile of areas in England to more than 60% in the least 
deprived quintile.10  A meta-analysis of uptake data from 14 RCT’s of BSS has indicated 
that uptake rates for BSS is likely to be lower than what is seen for gFOBt:11 one Dutch 
study found BSS uptake to be only 32.4%, compared to 49.5% for gFOBt.12  Other 
studies within this meta-analysis, however, have found BSS uptake to be higher e.g. a 
 RCT conducted in Italy showed a BSS uptake of 58.3%.13 However, methodological 
heterogeneity among the trials included in the meta-analysis (for example, with some 
recruiting from the general population, while others, including the UK FS trial, inviting 
individuals who had already indicated interest in screening), made it difficult to 
extrapolate to likely uptake in the national BSS programme. A recent population-based 
RCT conducted in Norway found BSS uptake to be 63%, but again with variation in 
methodology, direct comparisons with the UK national programme is difficult.8 
 
There have also been some small-scale evaluations of uptake. Two London-based 
feasibility studies of nurse-led BSS had uptake rates of 45% and 55%..14,15  However, 
both were delivered through a single screening centre known for its excellence in 
endoscopy, and served a population who may have been familiar with BSS screening 
due to the centre’s involvement in the UK FS trial.14,15 In 2011, a pathfinder study of 
BSS in three centres in England reported uptake of only 29%;16 however, none of these 
sites  used reminder letters for non-responders. With no publicity or marketing 
strategies in place, projection to uptake in the national programme is limited.   
 
Similarly, there is uncertainty with regard to gender differences in uptake of FS 
screening uptake. Women are more likely to return completed gFOBt kits, 9,17,18 but the 
opposite has been found for endoscopic screening. While the London-based feasibility 
studies indicated either similar or higher uptake for women,14,15 that was contrary to the 
UK FS trial data19,20 and other BSS uptake reports.12  
  
The present study is the first multi-centre examination of uptake in an organised BSS 
programme. The primary objective was to give an indication of overall uptake of BSS 
and examine differences by gender, socioeconomic status (SES) and ethnicity. A 
secondary aim was to compare uptake across the six participating centres, and assess 
the extent to which differences could be attributed to the demographic composition of 
the catchment populations.  
 
Finally, previous research has indicated that flexibility with regard to appointment day 
and/or time can influence attendance at various health-related appointments.21,22 We 
therefore also explored the extent to which the six centres offered out of hours 
appointments and whether offering these appointments was associated with increased 
uptake.  
 
 
MATERIALS AND METHODS 
Participants and setting  
The study population was all men and women who turned 55 during the study period 
(March 2013 – May 2014) and were registered at a general practice linked with the six 
screening centres (South of Tyne (Queen Elizabeth and South Tyneside); West Kent 
(West Kent and Medway); Norwich; London (St Marks); Wolverhampton, Surrey 
(Guildford)). Ethical approval for this study was not required. 
  
Invitation process 
The English BSS Programme sends a pre-invitation letter to all eligible individuals, 
informing them about the forthcoming BSS opportunity. A screening invitation letter, 
that offers a dated and timed screening appointment with approximately six weeks’ 
notice, is then sent 8-10 days later. During the invitation period covered in this study, of 
the six centres, five offered both weekday routine and evening/weekend (termed out-of-
hours) appointments, while one (Wolverhampton) offered only weekday routine 
appointments. Invitees are asked to either return a slip attached to  
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their invitation letter to confirm or decline attendance, or call the centre to confirm, 
rearrange, or cancel the appointment. 
 
Enclosed with the screening invitation is an information booklet about the programme 
and a freepost return envelope for the confirmation slip. After two weeks, an 
appointment reminder is sent to people who have not responded. For those who 
confirm the appointment, a confirmation letter is sent along with a consent form, which 
is followed shortly by a mailed enema with instructions for self-administration on the 
day of the appointment.  
 
 Measures 
The data used in this analysis were extracted and modified from data routinely 
collected within the BCSP. Data were anonymised before being transferred to the 
research team. 
 
Individual-level demographics. The gender of each invitee was added to the study 
dataset.  
 
Area-level deprivation. The postcode sector of each invitee was converted to a score 
for area-based socio-economic deprivation before being added to the study dataset. 
This score was derived using the 2010 Index of Multiple Deprivation (IMD).23 The IMD 
uses census-derived indicators of income, education, employment, living environment, 
health and disability, barriers to housing and services, and crime, at small-area level to 
generate a scale from 0 (least deprived) to 80 (most deprived). For analysis, the IMD 
scores were categorised into quintiles of the national distribution.24 
 
Area-level ethnic diversity. An area-level index of ethnic diversity was produced using 
Census 2010 data based on the proportion of ‘non-white’ residents (all self-reported 
ethnic groups other than ‘White British’, ‘White Irish’, and ‘White other’) in each 
postcode sector. For analysis, area-based ethnic diversity was grouped into quintiles 
based on national census information. 
 
 Appointment slot offered. The appointment date/time offered in the initial invitation 
letter was documented for each person. For analysis, appointments offered on 
weekday mornings and afternoons were categorised as ‘routine’, while appointments 
offered on weekday evenings (after 5pm) and Saturdays were categorised as ‘out-of-
hours’. 
 
Uptake. The date of attendance for individuals who attend is included in the 
programme database. Individuals with an entry for ‘date attended’ were classified as 
attending, and those with no date were classified as ‘Did not attend’ (DNA).  
 
Statistical analysis 
We categorised the continuous predictors (area level deprivation and ethnic diversity) 
using national quintiles of distribution. We used univariate logistic regression to 
examine differences in uptake by gender, deprivation quintile, ethnic diversity quintile, 
centre, and type of appointment offered. We used multivariate logistic regression to 
examine the independent effect of each predictor controlling for all others. Age group 
was not a variable in the analysis, as only 55 year olds are sent a BSS invitation. We 
report the results using odds ratios (ORs) and 95% confidence intervals (95% CI’s) 
(Table 1). Data were analysed with SPSS version 22. 
RESULTS 
Over the study period, 21,187 screening invitations were sent out across the six 
centres (see Appendix Table 1) with an overall uptake rate of 43.1% (N = 9,123). 
 Differences by gender, deprivation, ethnic diversity, centre, and type of appointment 
offered are shown in Table 1. Uptake varied between the six centres (36.8% - 52.0%); 
four centres had uptake significantly higher than the centre with the lowest uptake 
(South of Tyne). Men were more likely to attend BSS than women (44.6% vs 41.5%). 
 
Uptake in the least deprived quintile was 53.2% and only 32.7% for the most deprived 
quintile, with an almost linear trend across deprivation quintiles. This pattern was 
observed in all six centres, although the distribution of deprivation varied by centre (see 
Appendix Table 2). For example, Surrey had no invitees from the most deprived 
quintile while the majority of Wolverhampton’s invitees were from the most deprived 
quintile. Overall, uptake was significantly higher in the least ethnically diverse areas 
compared with the most ethnically diverse areas (44.9% vs. 38.7%), but there was no 
evidence of a gradient in relation to area ethnic diversity (see Table 2).  
 
Of the 21,187 appointments offered across the six centres, 49.7% (n = 10,533) were 
routine appointments (weekday morning and afternoons) and 50.3% (n = 10,654) were 
subsequently ‘out-of-hours’ (weekday evenings and Saturdays mornings and 
afternoons). The proportion of people who went on to attend an appointment and have 
the BSS procedure was significantly lower in the group originally offered a ‘routine’ 
appointment compared to those originally offered an ‘out-of-hours’ appointment (42.2% 
vs. 43.9%) (see Table 1). Closer inspection of the appointment data found attendance 
 at the exact appointment time and day offered was only 16.5% and 19.8% for ‘routine’ 
and ‘out-of-hours’ appointments respectively (see Table 2). 
 
A multivariate analysis confirmed that area-level deprivation remained the strongest 
independent predictor of uptake (OR for quintile 1 vs quintile 5 = 2.046, 95% CI 1.848, 
2.266) (see Table 1). Screening centre was also predictive of uptake with four centres 
achieving uptake levels significantly higher (15% to 38% higher) than the centre with 
the lowest uptake (South of Tyne). Gender also remained a significant predictor (OR = 
1.149, 95% confidence interval (CI) 1.087, 1.214). There was no independent effect of 
area-based ethnic diversity or the type of appointment offered. 
 
DISCUSSION 
England is the first country to begin to deliver a nationwide organised, population-
based, Bowel Scope Screening (BSS) programme, involving  
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flexible sigmoidoscopy examinations. Since the start of the programme in 2013, the six 
pilot centres have invited 21,187 people invited for BSS, of whom 43% attended. This 
was considerably higher compared with a recent Dutch trial comparing different 
screening modalities and the recent English pathfinder study.12,16 However, uptake was 
 lower than was reported for the two single-centre feasibility studies (45% and 55%) in 
the London area,14,15 and the early uptake for gFOBt screening (54%).10   
 
As documented in previous studies, uptake was strongly socioeconomically graded. 
Stratifying by quintile of area-level deprivation based on home address, uptake was 
almost twice as high in the least compared with most deprived areas (Table 1), and a 
similar gradient in uptake was seen in all six centres (see  Appendix Table 2). Given 
the potential benefits of BSS in reducing CRC incidence as well as mortality, such 
striking inequalities are a major concern. If strategies are not implemented to reduce 
the gradient, it is likely that inequalities in CRC incidence will be created and 
inequalities in CRC mortality will be excacerbated.10  
 
Similar to other studies investigating uptake of FS screening we found that women had 
lower uptake than men.12,19  This is surprising given that women are more  
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likely to participate in CRC screening using the  guaiac based FOBT kit,10 especially in 
the first invitation round.18 The reasons why this difference reverses for endoscopic 
screening tests is not well understood. Perhaps more importantly, very little is known 
about why there is an almost two-fold difference between uptake of BSS (41.5%) and 
coverage of breast and cervical screening (75.9 and 77.8%, respectively).25,26 A better 
 understanding of why women accept one invitation and decline the other could help to 
highlight the barriers to CRC screening.  
 
There were significant differences in uptake rates by centre after adjusting for 
differences in gender, SES, and area-based ethnic diversity. Furthermore, centre-
specific differences were not attenuated by adding a potentially modifiable service-
related variable (use of ‘out-of-hours’ appointments). While offering out-of-hours 
appointments was associated with slightly higher uptake in univariate analyses, the 
multivariate analysis suggested that it was not the offer of out-of-hours appointments 
per se, but the fact that they were preferentially offered to people who would have been 
more likely to attend on the basis of their demographic background (gender, area-
based deprivation and centre).  Importantly, there was large variation between centres 
in the type of appointments they offered. While the difference between routine and out 
of hours appointments was small it might be advisable for individual centres to offer a 
broader range of appointments (at least to begin with) to monitor whether there is a 
preference for specific appointment times or days among their target population.  
 
It is important to acknowledge that our analysis was restricted to the first six pilot 
centres, which covered only a fraction of the total population that will be eligible for 
BSS. The six pilot centres included in this analysis covered a population with a 
comparable level of deprivation to the rest of England (average IMD 2010 score 21.6 
vs 21.7 respectively).  In contrast, our analytic sample contained a higher proportion of 
 ethnically diverse individuals compared with the general population (20.8% vs 12.9%). 
Given the higher propensity of invitees from ethnically diverse areas, it is probable that 
uptake might increase slightly once the programme invites the entire eligible 
population.  
 
The finding that all our variables together have relatively low predictive power highlights 
the fact that there must be other important factors that could be targeted to improve 
uptake. These could include other service-related variables such as offering single-sex 
lists (i.e. endoscopy sessions inviting men or women only) and a choice of practitioner 
gender, and individual-level psychosocial variables (e.g. test-specific beliefs and 
attitudes, beliefs about CRC). Larger-scale data analysis will enable us to investigate 
other sources of centre differences, such as geographical variables while a mixture of 
prospective and retrospective interview studies and surveys will identify psychosocial 
determinants of uptake. Recent projections for the national programme in England 
suggest that adding once-only FS to the NHS BCSP will prevent an additional 2000 
CRC deaths and prevent 10,000 CRC cases in England by mid-2030. Importantly, this 
projection was based on 50% uptake of BSS and 57% uptake of gFOBT highlighting 
the potential benefits of increasing BSS uptake.9  Incentive to better understand 
predictors of BSS uptake and to incorporate this knowledge into the development of 
interventions to increase uptake is therefore high.   
 
 Because of the gradual roll-out of the programme there are currently no campaigns to 
encourage public awareness of BSS, unlike with other screening programmes. 
However, in light of the substantial health benefits of BSS screening, it is imperative 
that messages and communication channels are established to inform the public about 
BSS with a key objective being to narrow inequalities along with improving overall 
uptake.  
 
CONCLUSION 
The UK is a pioneer in delivery of organised endoscopic screening. Programme 
coverage is already good for a test that is intrusive and unfamiliar in the UK. 
Nevertheless, more than half of those invited do not attend, and this rises to two thirds 
for screening centres serving a predominantly socioeconomically deprived area. The 
huge health gain associated with preventing a common cancer that carries such high 
morbidity and mortality, makes a strong case for investment in strategies to both 
increase uptake and reduce social inequalities.  
 
Acknowledgements 
The authors of this paper would like to acknowledge our grant collaborators, Carly 
Porter, Hayley Miller, Jacqueline Underwood, and Sarah Marshall for their support with 
this research. 
Declarations of Interest 
All authors declare they have no conflicts of interest. 
  
Funding 
This work was supported by the Cancer Research UK [grant number C27064/A17326] 
to CVW. 
 
REFERENCES 
1. Cancer Research UK. Worldwide cancer incidence statistics, 
http://www.cancerresearchuk.org/cancer-info/cancerstats/world/incidence/ 
(2013, accessed 9 September 2014). 
2. Cancer Research UK. Worldwide cancer mortality statistic, 
http://www.cancerresearchuk.org/cancer-info/cancerstats/world/mortality/ 
(2013, accessed 9 September 2014). 
3. Cancer Research UK. Cancer mortality in the UK in 2012, 
http://publications.cancerresearchuk.org/publicationformat/formatstats/mortalit
y.html (2014, accessed 8 April 2015). 
4. Hewitson P, Glasziou P, Watson E, et al. Cochrane systematic review of 
colorectal cancer screening using the Fecal Occult Blood Test (Hemoccult): 
an update. Am J Gatroenterol 2008; 103: 1541- 1549. 
5. Atkin W, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy in 
prevention of colorectal cancer: a multicentre randomised controlled trial. 
Lancet 2010; 375: 1625-33. 
 6. Elmunzer J, Hayward R, Schoenfeld P, et al. Effect of flexible sigmoidoscopy-
based screening on incidence and mortality of colorectal cancer: A systematic 
review and meta-analysis of randomised controlled trials. PLOS Medicine 
2012; 9: 1-9.   
7. Holmes Ø, Bretthauer M, Fretheim A, Odgaard-Jensen J and Hoff G. Flexible 
sigmoidoscopy versus faecal occult blood testing for colorectal cancer 
screening in asymptomatic individuals. Cochrane Database Syst Rev 2013; 9: 
CD009259. DOI: 10.1002/14651858.CD009259.pub2. 
8. Holmes Ø, Løberg M, Kalager M, et al. Effect of flexible sigmoidoscopy 
screening on colorectal cancer incidence and mortality: a randomized clinical 
trial. JAMA 2014; 312: 606-615. 
9. Geurts SME, Massat NJ and Duffy SW. Likely effect of adding flexible 
sigmoidoscopy to the English NHS Bowel Cancer Screening Programme: 
impact on colorectal cancer cases and deaths. British Journal of Cancer 
2015; 113: 142-149. doi:10.1038/bjc.2015.76 
10. Von Wagner C, Baio G, Raine R, et al. Inequalities in participation in an 
organized national colorectal cancer screening programme: results from the 
first 2.6 million invitations in England. Int J Epidemiol 2011; 40: 712-8. 
11. Littlejohn C, Hilton S, Macfarlane GJ, et al. Systematic review and meta-
analysis of the evidence for flexible sigmoidoscopy as a screening method for 
the prevention of colorectal cancer. Br J Surg 2012; 99: 1488-1500. 
 12. Hol L, van Leerdam ME, van Ballegooijen M, et al. Screening for colorectal 
cancer: randomised trial comparing guaiac-based and immunochemical 
faecal occult blood testing and flexible sigmoidoscopy. Gut 2010; 59: 62-68. 
13. Segnan N, Senore C, Andreoni B, et al. Baseline findings of the Italian 
multicentre randomized controlled trial of “Once-Only Sigmoidoscopy – 
SCORE. Journal of the National Cancer Institute 2002; 94: 1763-1772. 
14. Robb K, Power E, Kralj-Hans I, et al. Flexible sigmoidoscopy screening for 
colorectal cancer: uptake in a population-based pilot programme. J Med 
Screen 2010; 17: 75-78. 
15. Brotherstone H, Vance M, Edwards R, et al. Uptake of population-based 
flexible sigmoidoscopy screening for colorectal cancer: a nurse-led feasibility 
study. J Med Screen 2007; 14: 76-80. 
16. Bevan R, Rubin G, Sofianopoulou E, et al. Implementing a national flexible 
sigmoidoscopy screening program: results of the English Early Pilot. 
Endoscopy 2014; 10: 827-915. 
17. Moss SM, Campbell C, Melia J et al. Performance measures in three rounds 
of the English bowel cancer screening pilot. Gut 2012; 61: 101-107. 
18. Lo SH, Halloran S, Snowball J, et al. Colorectal cancer screening uptake over 
three biennial invitation rounds in the English bowel cancer screening 
programme. Gut 2015; 64: 282-291.  
 19. UK Flexible Sigmoidoscopy Screening Trial Investigators. Single flexible 
sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a 
UK multicentre randomised trial. The Lancet 2002; 359: 1291-1300. 
20. Wardle J, Miles A, and Atkin W. Gender differences in utilization of colorectal 
cancer screening. J Med Screen 2005; 12: 20-27. 
21. Offman J, Wilson M, Lamont M, et al. A randomised trial of weekend and 
evening breast screening appointments. BJC 2013; 109: 597-602. 
22. Burgess C, Wright AJ, Forster AS, et al. Influences on individuals' decisions 
to take up the offer of a health check: a qualitative study. Health Expect. Epub 
ahead of print 3 June 2014. DOI: 10.1111/hex.12212. 
23. Department for Communities and Local Government. The English indices of 
deprivation 2010, https://www.gov.uk/government/statistics/english-indices-of-
deprivation-2010 (2011, accessed 8 April 2015). 
24. Public Health England. Adjusted IMD 2010 scores for 2011 LSOAs, 
http://www.apho.org.uk/resource/item.aspx?RID=125887 (2013, accessed 9 
April 2015). 
25. Health and Social Care Information Centre. Breast Screening Programme, 
England – 2013-2014, 
http://www.hscic.gov.uk/searchcatalogue?productid=17263&q=title%3a%22B
reast+Screening+Programme%2c+England%22&sort=Relevance&size=10&p
age=1#top (2015, accessed 8 April 2015). 
 26. Health and Social Care Information Centre. Cervical Screening Programme, 
England – 2013-2014, 
http://www.hscic.gov.uk/searchcatalogue?productid=16474&q=title%3a%22C
ervical+screening+programme%22&sort=Relevance&size=10&page=1#top 
(2014, accessed 8 April 2015). 
  
 Table 1: Demographic and service-level variation in screening uptake. 
  Univariate analysis Multivariate analysis* 
 
% Uptake (n) OR (95% CI) 
 
P value OR (95% CI) 
P 
value 
Centre      
     South of Tyne (n = 2858) 36.8 (1052) 1.000  1.000  
     West Kent (n = 3689) 47.4 (1747) 1.544 (1.398, 1.706) <0.001 1.184 (1.049, 1.336)   0.006 
     Norwich (n = 3776) 50.6 (1909) 1.755 (1.590, 1.938) <0.001 1.376 (1.238, 1.529) <0.001 
     London (St Mark’s) (n = 4933) 40.5 (1997) 1.168 (1.062, 1.284)   0.001 1.173 (1.034, 1.332)   0.013 
     Wolverhampton (n = 4551) 37.4 (1700) 1.024 (0.929, 1.128)   0.636 1.012 (0.890, 1.151)   0.857 
     Surrey (n = 1380) 52.0 (718) 1.862 (1.635, 2.121) <0.001 1.149 (1.052, 1.437)   0.009 
Gender      
     Women (n = 10619) 41.5 (4407) 1.000  1.000  
     Men (n = 10568) 44.6 (4716) 1.136 (1.076, 1.199) <0.001 1.149 (1.087, 1.214) <0.001 
 Area-based deprivation quintiles  
     Quintile 1, mMost deprived (n = 
4336) 
32.7 (1416) 1.000  1.000  
     Quintile 2 (n = 4413) 37.8 (1669) 1.254 (1.149, 1.370) <0.001 1.198 (1.094, 1.312) <0.001 
     Quintile 3  (n = 4100) 43.0 (1765) 1.559 (1.427, 1.703) <0.001 1.443 (1.315, 1.584) <0.001 
     Quintile 4  (n = 4016) 49.1 (1973) 1.991 (1.823, 2.176) <0.001 1.766 (1.602, 1.947) <0.001 
     Quintile 5, lLeast deprived (n = 4303) 53.2 (2289) 2.344 (2.148, 2.557) <0.001 2.046 (1.848, 2.266) <0.001 
Area-based ethnic diversity quintiles 
     Quintile 1, mMost diverse (n = 4608) 38.7 (1783) 1.000  1.000  
     Quintile 2 (n = 4462) 41.2 (1838) 1.110 (1.020, 1.207)   0.015 1.065 (0.959, 1.182)   0.241 
     Quintile 3  (n = 4292) 44.1 (1892) 1.249 (1.148, 1.359) <0.001 1.025 (0.915, 1.149)   0.666 
     Quintile 4  (n = 3976) 47.3 (1879) 1.420 (1.303, 1.547) <0.001 1.115 (0.991, 1.255)   0.071 
     Quintile 5, lLeast diverse (n = 3830) 44.9 (1720) 1.292 (1.184, 1.409) <0.001 1.064 (0.942, 0.201)   0.316 
Type of appointment offered 
     Out-of-hours (n = 10654) 43.9% (4680) 1.000  1.000   
      Routine (n = 10533)  42.2% (4443) 0.931 (0.882, 0.983)   0.010 1.062 (0.981, 1.149)   0.138 
*Controlled for all variables 
 
 Table 2: Proportion of appointment times offered, attended and re-scheduled 
 Changed appointment 
Appointment 
slot offered Offered 
Overall 
Attendance 
Attendance at 
exact 
appointment 
offered 
Attended 
appointment 
within slot 
Attended a 
different 
appointment slot 
Routine  
10533 
(49.7%) 
4443 (42.2%) 1737 (16.5%) 2301 (51.8%) 405 (9.1%) 
Out-of-hours  
10654 
(50.3%) 
4680 (43.9%) 2107 (19.8%) 2090 (44.7%) 483 (10.3%) 
Total 21187 9123 (43.1%) 3844 (18.1%) 4391 (48.1%) 888 (9.7%) 
 
 Figure 1: Flowchart of proposed national roll-out of centres offering Bowel Scope screening 
 
 
 
 
 
 
Pilot       
Centres 
March 2013              
to                     
July 2013 
6 Centres 
Wave 1 
Centres 
November 2013              
to                  
March 2014 
16 (22) Centres 
Wave 2 
Centres 
April 2014              
to                  
March 2015 
17 (39) Centres 
Final Rollout of 
Centres 
April 2015                    
to                        
December 2016 
 23 (62) Centres  
 Appendix Table 1: Proportion of people invited across each centre by area-based deprivation quintile (row percentages) and 
proportion of people invited for each deprivation quintile by centre (column percentages).  
 IMD Quintile  
 Q1 
(Most          
deprived) 
Q2 Q3 Q4 Q5 
(Least          
deprived) 
Total 
South of Tyne       
% within centre 38.1 23.2 18.0 10.0 10.7 100.0 
% within IMD Quintile 25.1 15.0 12.5 7.1 7.1 13.5 
(n) (1087) (662) (514) (287) (306) (2856) 
West Kent       
% within centre 4.5 16.4 17.5 27.6 34.0 100.0 
% within IMD Quintile 3.8 13.7 15.8 25.3 29.1 17.4 
 (n) (165) (604) (646) (1017) (1252) (3684) 
Norwich       
% within centre 6.0 9.2 21.6 33.7 29.6 100.0 
% within IMD Quintile 5.2 7.8 19.9 31.7 25.9 17.8 
(n) (225) (346) (815) (1272) (1115) (3773) 
London (St Marks)       
% within centre 18.3 37.4 25.1 12.3 6.8 100.0 
% within IMD Quintile 20.8 41.8 30.2 15.1 7.8 23.3 
(n) (903) (1843) (1238) (607) (337) (4928) 
Wolverhampton       
% within centre 43.0 19.9 16.2 13.5 7.4 100.0 
% within IMD Quintile 45.1 20.5 18.0 15.3 7.8 21.5 
 (n) (1956) (904) (736) (616) (337) (4549) 
Surrey       
% within centre 0.0 3.9 11.0 15.7 69.4 100.0 
% within IMD Quintile 0.0 1.2 3.7 5.4 22.2 6.5 
(n) (0) (54) (151) (217) (956) (1378) 
Total       
% within centre 20.5 20.8 19.4 19.0 20.3 100.0 
% within IMD Quintile 100.0 100.0 100.0 100.0 100.0 100.0 
(n) (4336) (4413) (4100) (4016) (4303) (21168)* 
*IMD scores were not available for 19 participants across 4 centres 
 Appendix Table 2: Demographic and service-level variation in screening uptake in the six pilot centres. 
 South of Tyne 
% (n=2,858) 
West Kent                
% (n=3,689) 
Norwich                   
% (n=3,776) 
London                     
% (n=4,933) 
Wolverhampton    
% (n=4,551)  
Surrey                         
% (n=1,380) 
Overall uptake 36.8 47.4 50.6 40.5 37.4 52.0  
Gender       
   Men 39.4  
(564/1432) 
48.3  
(878/1,817) 
52.6  
(974/1,853) 
41.1  
(1,007/2,449) 
39.7  
(912/2,300) 
53.1  
(381/717) 
   Women 34.2  
(488/1426) 
46.4  
(869/1,872) 
48.6  
(935/1,923) 
39.9  
(990/2,484) 
35.0  
(788/2,251) 
50.8  
(337/663) 
Area-based deprivation quintiles       
   Quintile 1 (Most deprived)  29.5  
(321/1,087) 
38.2  
(63/165) 
38.2  
(86/225) 
35.3  
(319/903) 
32.1  
(627/1,956) 
0 
(0) 
    Quintile 2  35.3  
(234/662) 
39.9  
(241/604) 
45.7  
(158/346) 
37.5  
(692/1,843) 
35.5  
(321/904) 
42.6  
(23/54) 
   Quintile 3  41.6  
(214/514) 
43.0  
(278/646) 
46.3  
(377/815) 
42.7  
(529/1,238) 
41.4  
(305/736) 
41.1  
(62/151) 
   Quintile 4  46.3  
(133/287) 
49.3  
(501/1,017) 
52.4  
(667/1,272) 
47.0  
(285/607) 
46.6  
(287/616) 
46.1  
(100/217) 
   Quintile 5 (Least deprived) 49.0  
(150/306) 
52.7  
(660/1,252) 
55.5  
(619/1,115) 
50.1  
(169/337) 
47.5  
(160/337) 
55.5  
(531/956) 
Area-based ethnic diversity quintiles      
   Quintile 1 (Most diverse) 48.3  
(28/58) 
42.1  
(51/121) 
44.4  
(40/90) 
38.9  
(1,418/3,644) 
34.6  
(229/661) 
50.0  
(17/34) 
   Quintile 2  34.3  45.3  52.2  41.8  36.9  52.6  
 (92/268) (340/751) (107/205) (269/643) (788/2,135) (242/460) 
   Quintile 3  32.4  
(119/367) 
46.9  
(757/1,614) 
54.7  
(237/433) 
43.8  
(84/192) 
36.8  
(437/1,187) 
51.7  
(258/499) 
   Quintile 4  39.4  
(370/939) 
49.7  
(448/901) 
50.5  
(658/1,303) 
47.6  
(91/191) 
45.1  
(148/328) 
52.2  
(164/314) 
   Quintile 5 (Least diverse) 36.2  
(443/1,224) 
49.5  
(147/297) 
49.7  
(865/1,742) 
51.2  
(132/258) 
41.2  
(98/238) 
49.3  
(35/71) 
Type of appointment offered      
   Out-of-hours appointment 36.1  
(896/2,480) 
44.8  
(499/1,115) 
50.6  
(1,887/3,730) 
40.5  
(1,225/3,023) 
0 
(0) 
56.5  
(173/306) 
   Routine appointment 41.3  
(156/378) 
48.5 
(1,248/2,574) 
47.8  
(22/46) 
40.4  
(772/1,910) 
37.4  
(1,700/4,551) 
50.7  
(545/1,074) 
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